For families and patients wanting more information about Allo Phase 2 Clinical Trial: LEARN MORE

For symptomatic peri- and post menopausal women interested in information regarding clinical trial to test the safety and efficacy of PhytoSERM, a potential alternative to hormone therapy. LEARN MORE

Why is Alzheimer’s so complicated?

The Atlantic magazine features Dr. Roberta Diaz Brinton, her research journey, and why today’s Alzheimer’s research is moving from a one-size-fits-all approach to more personalized medicine strategies. The University of Arizona Center for Innovation in Brain Scienis working to develop the first regenerative therapeutic for a disease that is expected to affect more than 7.7 million people by 2030.

The Atlantic:Rethink – Alzheimer’s is More Complicated Than We Thought

Leave a Reply

Your email address will not be published.

The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2021 Center for Innovation Brain Science. University of Arizona Health Sciences.